Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aprogen/Nichi-Iko's Remicade Biosimilar Clears Japan’s Approval Review

Aug 09 2017

• By Jung Won Shin

Japanese flag

Related Content

Aprogen Strikes Third Global Biosimilar Deal With Nichi-Iko

Mar 25 2016

Nichi-Iko Buys Sagent To Strengthen US Biosimilars Presence

Jul 12 2016

Related Companies

Celltrion, Inc.

Samsung Bioepis Co., Ltd.

Nichi-Iko Pharmaceutical Co., Ltd.

Nichi-Iko Pharmaceutical Co., Ltd.

Additional Topics

Japan Asia Pacific South Korea Biosimilars Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window